{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:10:45Z","timestamp":1791227445402,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1038\/ejhg.2010.198","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T14:07:25Z","timestamp":1291817245000},"page":"472-478","source":"Crossref","is-referenced-by-count":117,"title":["Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling"],"prefix":"10.1038","volume":"19","author":[{"given":"Robert R","family":"McWilliams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D","family":"Wieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari G","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina S","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Sicotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria M","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"key":"BFejhg2010198_CR1","first-page":"17","volume":"99","author":"HT Lynch","year":"1968","unstructured":"Lynch HT, Krush AJ : Heredity and malignant melanoma: implications for early cancer detection. Can Med Assoc J 1968; 99: 17\u201321.","journal-title":"Can Med Assoc J"},{"key":"BFejhg2010198_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJM199510123331504","volume":"333","author":"AM Goldstein","year":"1995","unstructured":"Goldstein AM, Fraser MC, Struewing JP et al: Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. New Engl J Med 1995; 333: 970\u2013974.","journal-title":"New Engl J Med"},{"key":"BFejhg2010198_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/00000658-200212000-00005","volume":"236","author":"DK Bartsch","year":"2002","unstructured":"Bartsch DK, Sina-Frey M, Lang S et al: CDKN2A germline mutations in familial pancreatic cancer. Ann Surg 2002; 236: 730\u2013737.","journal-title":"Ann Surg"},{"key":"BFejhg2010198_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cncr.10159","volume":"94","author":"HT Lynch","year":"2002","unstructured":"Lynch HT, Brand RE, Hogg D et al: Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 2002; 94: 84\u201396.","journal-title":"Cancer"},{"key":"BFejhg2010198_CR5","first-page":"3126","volume":"57","author":"M Schutte","year":"1997","unstructured":"Schutte M, Hruban RH, Geradts J et al: Abrogation of the Rb\/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997; 57: 3126\u20133130.","journal-title":"Cancer Res"},{"key":"BFejhg2010198_CR6","first-page":"14","volume":"30","author":"F Jing","year":"2007","unstructured":"Jing F, Zhang J, Tao J et al: Hypermethylation of tumor suppressor genes BRCA1, p16 and 14\u20133\u20133sigma in serum of sporadic breast cancer patients. Onkologie 2007; 30: 14\u201319.","journal-title":"Onkologie"},{"key":"BFejhg2010198_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/jmg.2005.031476","volume":"42","author":"T Debniak","year":"2005","unstructured":"Debniak T, Gorski B, Huzarski T et al: A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 2005; 42: 763\u2013765.","journal-title":"J Med Genet"},{"key":"BFejhg2010198_CR8","doi-asserted-by":"publisher","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","volume":"14","author":"FA de Snoo","year":"2008","unstructured":"de Snoo FA, Bishop DT, Bergman W et al: Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 2008; 14: 7151\u20137157.","journal-title":"Clin Cancer Res"},{"key":"BFejhg2010198_CR9","first-page":"2298","volume":"58","author":"M Bahuau","year":"1998","unstructured":"Bahuau M, Vidaud D, Jenkins RB et al: Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 1998; 58: 2298\u20132303.","journal-title":"Cancer Res"},{"key":"BFejhg2010198_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/jnci\/88.20.1489","volume":"88","author":"WG Yarbrough","year":"1996","unstructured":"Yarbrough WG, Aprelikova O, Pei H, Olshan AF, Liu ET : Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 1996; 88: 1489\u20131491.","journal-title":"J Natl Cancer Inst"},{"key":"BFejhg2010198_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/375503a0","volume":"375","author":"J Lukas","year":"1995","unstructured":"Lukas J, Parry D, Aagaard L et al: Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995; 375: 503\u2013506.","journal-title":"Nature"},{"key":"BFejhg2010198_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/CEJ.0b013e3282f75eb1","volume":"17","author":"Ta Debniak","year":"2008","unstructured":"Debniak Ta, van de Wetering Ta, Scott Re et al: Low prevalence of CDKN2A\/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland. Eur J Cancer Prev 2008; 17: 389\u2013391.","journal-title":"Eur J Cancer Prev"},{"key":"BFejhg2010198_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/annonc\/mdg498","volume":"15","author":"P Ghiorzo","year":"2004","unstructured":"Ghiorzo P, Pastorino L, Bonelli L et al: INK4\/ARF germline alterations in pancreatic cancer patients. Ann Oncol 2004; 15: 70\u201378.","journal-title":"Ann Oncol"},{"key":"BFejhg2010198_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","volume":"87","author":"HFA Vasen","year":"2000","unstructured":"Vasen HFA, Gruis NA, Frants RR, van der Velden PA, Hille ETM, Bergman W : Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809\u2013811.","journal-title":"Int J Cancer"},{"key":"BFejhg2010198_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1158\/1055-9965.EPI-08-1109","volume":"18","author":"RR McWilliams","year":"2009","unstructured":"McWilliams RR, Bamlet WR, de Andrade M, Rider DN, Cunningham JM, Petersen GM : Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev 2009; 18: 1295\u20131302.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFejhg2010198_CR16","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/nar\/25.14.2745","volume":"25","author":"DA Nickerson","year":"1997","unstructured":"Nickerson DA, Tobe VO, Taylor SL : PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997; 25: 2745\u20132751.","journal-title":"Nucleic Acids Res"},{"key":"BFejhg2010198_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/0471249688","volume-title":"Categorical Data Analysis","author":"A Agresti","year":"2002","unstructured":"Agresti A : Categorical Data Analysis, 2nd edn, John Wiley & Sons: Hoboken, NJ, 2002."},{"key":"BFejhg2010198_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.0006-341X.2001.00245.x","volume":"57","author":"N Chatterjee","year":"2001","unstructured":"Chatterjee N, Wacholder S : A marginal likelihood approach for estimating penetrance from kin-cohort designs. Biometrics 2001; 57: 245\u2013252.","journal-title":"Biometrics"},{"key":"BFejhg2010198_CR19","first-page":"6864","volume":"60","author":"J Hashemi","year":"2000","unstructured":"Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J : CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res 2000; 60: 6864\u20136867.","journal-title":"Cancer Res"},{"key":"BFejhg2010198_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/jmg.2007.055376","volume":"45","author":"AM Goldstein","year":"2008","unstructured":"Goldstein AM, Stacey SN, Olafsson JH et al: CDKN2A mutations and melanoma risk in the Icelandic population. J Med Gen 2008; 45: 284\u2013289.","journal-title":"J Med Gen"},{"key":"BFejhg2010198_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/sj.jid.5700293","volume":"126","author":"T Spica","year":"2006","unstructured":"Spica T, Portela M, Gerard B et al: The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol 2006; 126: 1657\u20131660.","journal-title":"J Invest Dermatol"},{"key":"BFejhg2010198_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng0994-15","volume":"8","author":"CJ Hussussian","year":"1994","unstructured":"Hussussian CJ, Struewing JP, Goldstein AM et al: Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15\u201321.","journal-title":"Nat Genet"},{"key":"BFejhg2010198_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kamb","year":"1994","unstructured":"Kamb A, Shattuck-Eidens D, Eeles R et al: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994; 8: 23\u201326.","journal-title":"Nat Genet"},{"key":"BFejhg2010198_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/CMR.0b013e328014a2cd","volume":"17","author":"D Pjanova","year":"2007","unstructured":"Pjanova D, Engele L, Randerson-Moor JA et al: CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Melanoma Res 2007; 17: 185\u2013191.","journal-title":"Melanoma Res"},{"key":"BFejhg2010198_CR25","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","volume":"66","author":"AM Goldstein","year":"2006","unstructured":"Goldstein AM, Chan M, Harland M et al: High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 2006; 66: 9818\u20139828.","journal-title":"Cancer Res"},{"key":"BFejhg2010198_CR26","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/jnci\/dji312","volume":"97","author":"CB Begg","year":"2005","unstructured":"Begg CB, Orlow I, Hummer AJ et al: Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005; 97: 1507\u20131515.","journal-title":"J Natl Cancer Inst"},{"key":"BFejhg2010198_CR27","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1200\/JCO.2007.13.5624","volume":"25","author":"P Ghiorzo","year":"2007","unstructured":"Ghiorzo P, Gargiulo S, Nasti S et al: Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy. J Clin Oncol 2007; 25: 5336\u20135337.","journal-title":"J Clin Oncol"},{"key":"BFejhg2010198_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1525-1578(10)60667-8","volume":"3","author":"I Orlow","year":"2001","unstructured":"Orlow I, Roy P, Barz A, Canchola R, Song Y, Berwick M : Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations. J Mol Diagn 2001; 3: 158\u2013163.","journal-title":"J Mol Diagn"},{"key":"BFejhg2010198_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/humu.9247","volume":"23","author":"AM Goldstein","year":"2004","unstructured":"Goldstein AM : Familial melanoma, pancreatic cancer and germline CDKN2A mutations. Hum Mutat 2004; 23: 630.","journal-title":"Hum Mutat"},{"key":"BFejhg2010198_CR30","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1038\/sj.onc.1206564","volume":"22","author":"JL Rutter","year":"2003","unstructured":"Rutter JL, Goldstein AM, Davila MR, Tucker MA, Struewing JP : CDKN2A point mutations D153spl(c.457G&gt;T) and IVS2+1G&gt;T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene 2003; 22: 4444\u20134448.","journal-title":"Oncogene"},{"key":"BFejhg2010198_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/5082","volume":"21","author":"L Liu","year":"1999","unstructured":"Liu L, Dilworth D, Gao L et al: Mutation of the CDKN2A 5\u2032 UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet 1999; 21: 128\u2013132.","journal-title":"Nat Genet"},{"key":"BFejhg2010198_CR32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/0008-5472.835.65.3","volume":"65","author":"T Debniak","year":"2005","unstructured":"Debniak T, Scott RJ, Huzarski T et al: CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res 2005; 65: 835\u2013839.","journal-title":"Cancer Res"},{"key":"BFejhg2010198_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cncr.10159","volume":"94","author":"HT Lynch","year":"2002","unstructured":"Lynch HT, Brand RE, Hogg D et al: Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 2002; 94: 84\u201396.","journal-title":"Cancer"},{"key":"BFejhg2010198_CR34","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","volume":"92","author":"A Borg","year":"2000","unstructured":"Borg A, Sandberg T, Nilsson K et al: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000; 92: 1260\u20131266.","journal-title":"J Natl Cancer Inst"},{"key":"BFejhg2010198_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/jmg.2004.019349","volume":"41","author":"AM Goldstein","year":"2004","unstructured":"Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA : Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet 2004; 41: 421\u2013424.","journal-title":"J Med Genet"},{"issue":"4","key":"BFejhg2010198_CR36","doi-asserted-by":"publisher","first-page":"677.e1-677.e14","DOI":"10.1016\/j.jaad.2009.03.016","volume":"61","author":"Sancy A. Leachman","year":"2009","unstructured":"Leachman SA, Carucci J, Kohlmann W et al: Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad of Dermatol 2009; 61: 677.e1\u2013677.e14.","journal-title":"Journal of the American Academy of Dermatology"},{"key":"BFejhg2010198_CR37","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1470-2045(04)01469-X","volume":"5","author":"CB Hansen","year":"2004","unstructured":"Hansen CB, Wadge LM, Lowstuter K, Boucher K, Leachman SA : Clinical germline genetic testing for melanoma. Lancet Oncol 2004; 5: 314\u2013319.","journal-title":"Lancet Oncol"},{"key":"BFejhg2010198_CR38","first-page":"214","volume":"107","author":"M Mantelli","year":"2002","unstructured":"Mantelli M, Barile M, Ciotti P et al: High prevalence of the G101W germline mutation in the CDKN2A (P16\/ink4a) gene in 62 Italian malignant melanoma families. Am J Med Genet 2002; 107: 214\u2013221.","journal-title":"Am J Med Genet"},{"key":"BFejhg2010198_CR39","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1093\/jnci\/86.20.1510","volume":"86","author":"DT Silverman","year":"1994","unstructured":"Silverman DT, Dunn JA, Hoover RN et al: Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510\u20131516.","journal-title":"J Natl Cancer Inst"},{"key":"BFejhg2010198_CR40","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1001\/archinte.1996.00440180119015","volume":"156","author":"CS Fuchs","year":"1996","unstructured":"Fuchs CS, Colditz GA, Stampfer MJ et al: A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156: 2255\u20132260.","journal-title":"Arch Intern Med"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2010198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2010198","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2010198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T12:18:04Z","timestamp":1685881084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2010198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["BFejhg2010198"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2010.198","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}